Home » Topics » BioWorld Science

BioWorld Science
RSS

Ainos reports preclinical data on low-dose oral interferon-alpha Veldona against COVID-19

June 28, 2022

Use of [89Zr]Prot-FH for neutrophil imaging during fungal infection

June 28, 2022

New pH-responsive albumin-binding ligands show targeted tumor uptake in vivo

June 28, 2022

EAN 2022: At several scales, connective landscape provides lens for neurology

June 28, 2022

RBM22 inversely correlates with prostate cancer aggressiveness

June 28, 2022

IMPACT Therapeutics synthesizes new NUAK inhibitors

June 28, 2022

Chinese researchers identify new JAK1 inhibitors

June 28, 2022

Chengdu Easton Biopharmaceuticals discloses BET inhibitors

June 28, 2022

Targeting of CD46 allows PET imaging of mesothelioma with [89Zr]DFO-YS5

June 28, 2022

Suzhou Vincentage Pharma patents GLP-1 receptor agonists

June 28, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...